611 related articles for article (PubMed ID: 17975472)
21. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
Wiest R; Groszmann RJ
Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
[TBL] [Abstract][Full Text] [Related]
22. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
23. Etiology and pathophysiology of portal hypertension.
Reichen J
Z Gastroenterol; 1988 Sep; 26 Suppl 2():3-7. PubMed ID: 3055716
[TBL] [Abstract][Full Text] [Related]
24. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
Gatta A; Bolognesi M; Sacerdoti D; Merkel C
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
[TBL] [Abstract][Full Text] [Related]
25. Fibrosis and cirrhosis reversibility: clinical features and implications.
Pinzani M; Vizzutti F
Clin Liver Dis; 2008 Nov; 12(4):901-13, x. PubMed ID: 18984473
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
[No Abstract] [Full Text] [Related]
27. Mechanisms of extrahepatic vasodilation in portal hypertension.
Hennenberg M; Trebicka J; Sauerbruch T; Heller J
Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
[TBL] [Abstract][Full Text] [Related]
28. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
[TBL] [Abstract][Full Text] [Related]
29. Current concepts on the role of nitric oxide in portal hypertension.
Hu LS; George J; Wang JH
World J Gastroenterol; 2013 Mar; 19(11):1707-17. PubMed ID: 23555159
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of portal hypertensive gastropathy: an unresolved issue.
Lo GH
J Gastroenterol Hepatol; 2009 Sep; 24(9):1482-3. PubMed ID: 19743994
[No Abstract] [Full Text] [Related]
31. [Circulatory dysfunction syndrome associated with liver cirrhosis].
Hartleb M
Przegl Epidemiol; 2005; 59(2):549-58. PubMed ID: 16190566
[TBL] [Abstract][Full Text] [Related]
32. [Pathogenesis of portal hypertension].
Montaño-Loza A; Meza-Junco J
Rev Invest Clin; 2005; 57(4):596-607. PubMed ID: 16315644
[TBL] [Abstract][Full Text] [Related]
33. [Blocked suprahepatic pressure and the portohepatic gradient in evaluation of the portal circulation (author's transl)].
Cortinovis A; Crippa A; Bellorini R; Pedroni G
Chir Ital; 1980 Oct; 32(5):964-85. PubMed ID: 7018716
[TBL] [Abstract][Full Text] [Related]
34. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
Gatta A; Bolognesi M; Merkel C
Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
[TBL] [Abstract][Full Text] [Related]
35. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
[TBL] [Abstract][Full Text] [Related]
36. Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.
Coch L; Mejias M; Berzigotti A; Garcia-Pras E; Gallego J; Bosch J; Mendez R; Fernandez M
Hepatology; 2014 Aug; 60(2):633-47. PubMed ID: 24390792
[TBL] [Abstract][Full Text] [Related]
37. Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.
Møller S; Henriksen JH; Bendtsen F
World J Gastroenterol; 2014 Nov; 20(42):15499-517. PubMed ID: 25400435
[TBL] [Abstract][Full Text] [Related]
38. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.
Bosch J; Pizcueta MP; Fernández M; Feu F; Cirera I; Luca A; García-Pagán JC
Baillieres Clin Gastroenterol; 1992 Sep; 6(3):425-36. PubMed ID: 1421593
[TBL] [Abstract][Full Text] [Related]
39. Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis.
Hsu SJ; Wang SS; Hsin IF; Lee FY; Huang HC; Huo TI; Lee WS; Lin HC; Lee SD
Clin Sci (Lond); 2014 May; 126(9):633-44. PubMed ID: 24063570
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis.
Langer DA; Shah VH
J Hepatol; 2006 Jan; 44(1):209-16. PubMed ID: 16297493
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
